(19)
(11) EP 3 144 319 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 2 (W2 B1)

(48) Corrigendum issued on:
25.09.2019 Bulletin 2019/39

(45) Mention of the grant of the patent:
22.05.2019 Bulletin 2019/21

(21) Application number: 16195839.2

(22) Date of filing: 19.09.2012
(51) International Patent Classification (IPC): 
C07K 14/78(2006.01)
C12N 5/00(2006.01)
C12N 5/074(2010.01)
C12M 1/12(2006.01)
 C07K 14/705(2006.01)
C12M 3/00(2006.01)
C12N 5/0735(2010.01)

(54)

CELL CULTURE COMPOSITION COMPRISING LAMININ-521

ZELLKULTURZUSAMMENSETZUNG MIT LAMININ-521

COMPOSITION DE CULTURE CELLULAIRE COMPRENANT LAMININE-521

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 22.09.2011 US 201161537940 P
30.11.2011 US 201161565380 P
01.12.2011 US 201161565849 P
16.04.2012 US 201261624588 P
17.04.2012 US 201261625321 P

(43) Date of publication of application:
22.03.2017 Bulletin 2017/12

(62) Application number of the earlier application in accordance with Art. 76 EPC:
12798366.6 / 2758427

(73) Proprietor: BioLamina AB
172 66 Sundbyberg (SE)

(72) Inventors:
  • Tryggvason, Karl
    182 61 Djursholm (SE)
  • Rodin, Sergey
    11346 Stockholm (SE)

(74) Representative: Novitas Patent AB 
P.O. Box 55557
102 04 Stockholm
102 04 Stockholm (SE)


(56) References cited: : 
WO-A1-2012/080844
 WO-A2-2008/084401
   
  • SUSAN M BURDEN-GULLEY ET AL: "L1, N-cadherin, and Laminin Induce Distinct Distribution Patterns of Cytoskeletal Elements in Growth Cones", CELL MOTILITY AND THE CYTOSKELETON, vol. 35, 1 January 1996 (1996-01-01), pages 1-23, XP055331991, DOI: 10.1002/(SICI)1097-0169(1996)35:1<1::AID-C M1>3.0.CO;2-F
  • MASATO NAGAOKA ET AL: "Culture of human pluripotent stem cells using completely defined conditions on a recombinant E-cadherin substratum", BMC DEV BIOL, vol. 10, 2 June 2010 (2010-06-02), XP055127261, DOI: 10.1186/1471-213X-10-60
  • RODIN SERGEY ET AL: "Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511", NATURE BIOTECHNOLOGY, GALE GROUP INC, US, vol. 28, no. 6, 1 June 2010 (2010-06-01), pages 611-615, XP009135150, ISSN: 1087-0156
  • LUDWIG TENNEILLE E ET AL: "Feeder-independent culture of human embryonic stem cells", HHS PUBLIC ACCESS AUTHOR MANUSCRIPT, NATURE PUBLISHING GROUP, GB, vol. 3, no. 8, 1 August 2006 (2006-08-01), pages 637-646, XP008084296, ISSN: 1548-7091, DOI: 10.1038/NMETH902
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).